Chronic Infections and Inflammation in ME/CFS: An Observational Study

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07227441
Status
Recruiting
Apply to this trial

Conditions

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

CHIIME is a study of people who have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). People who do not have this condition will also be enrolled. Volunteers will be observed and sampled over time to identify the long-terms biological drivers and impact of their condition. The overall goal is to understand the biological and physiological mechanisms that are driving this condition.

Key Dates

Start date
Jan 1, 2026
Status verified
Mar 2026
Primary completion
Sep 30, 2030
Completion
Sep 30, 2030

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Non-COVID ME/CFS
    Individuals who received a diagnosis of ME/CFS prior to the beginning of SARS-CoV-2 pandemic and whom SARS-CoV-2 was not expected to be the driver of ME/CFS
  • Arm: Post-COVID ME/CFS
    Individuals who received a diagnosis of ME/CFS following the beginning of the SARS-CoV-2 pandemic and in who SARS-CoV-2 was expected to be the driver of ME/CFS
  • Arm: Healthy control
    Individuals who have overlapping demographic characteristics (age, sex, race, and other factors determined by PI) with participants who have ME/CFS

Primary Outcome Measure

Participant Sex [ Time Frame: Baseline Visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Zuckerberg San Francisco General HospitalSan FranciscoCalifornia94110-

Find similar trials in San Francisco, CA

By research site
Zuckerberg San Francisco General Hospital· San Francisco, CA

Related Studies